HIV-1 Drug Resistance in the iPrEx Preexposure Prophylaxis Trial-Reference-Cited by-同舟云学术

HIV-1 Drug Resistance in the iPrEx Preexposure Prophylaxis Trial

Published:2014-04-16 Issue:8 Volume:210 Page:1217-1227
ISSN:0022-1899
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:

Author:

Liegler Teri¹²,Abdel-Mohsen Mohamed¹,Bentley L. Gordon³,Atchison Robert³,Schmidt Timothy²,Javier Jacqueline²,Mehrotra Megha³,Eden Christopher³,Glidden David V.⁴,McMahan Vanessa³,Anderson Peter L.⁵,Li Peilin⁶,Wong Joseph K.⁶,Buchbinder Susan⁷,Guanira Juan V.⁸,Grant Robert M.¹³

Affiliation:

1. Department of Medicine, University of California

2. AIDS Research Institute, University of California

3. J. David Gladstone Institutes

4. Department of Epidemiology, University of California, San Francisco

5. Department of Pharmaceutical Sciences, University of Colorado Denver, Aurora

6. Veterans Affairs Medical Center, San Francisco

7. Bridge HIV, San Francisco Department of Public Health, California

8. Asociación Civil Impacta Salud y Educación, Lima, Peru

Funder

The Division of Acquired Immunodeficiency Syndrome (DAIDS), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)

the Bill and Melinda Gates Foundation; a cooperative agreement with DAIDS

the University of California at San Francisco was provided by DAIDS

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/210/8/1217/13804984/jiu233.pdf

Reference50 articles.

1. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women;Abdool Karim;Science,2010

2. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women;Baeten;N Engl J Med,2012

3. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men;Grant;N Engl J Med,2010